Patrick N. Cunningham to Humans
This is a "connection" page, showing publications Patrick N. Cunningham has written about Humans.
Connection Strength
0.108
-
Chronic Microangiopathy Due to DCR-MYC, a Myc-Targeted Short Interfering RNA. Am J Kidney Dis. 2020 04; 75(4):513-516.
Score: 0.024
-
Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers. PLoS One. 2019; 14(9):e0221957.
Score: 0.024
-
The future of pharmacogenetics in the treatment of hypertension. Pharmacogenomics. 2019 02; 20(3):129-132.
Score: 0.023
-
Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol. 2005 May; 16(5):1214-22.
Score: 0.009
-
The Epidemiologic Burden of Tacrolimus Variability among Kidney Transplant Recipients in the United States. Am J Nephrol. 2019; 50(5):370-374.
Score: 0.006
-
Bowman capsulitis predicts poor kidney allograft outcome in T cell-mediated rejection. Hum Pathol. 2018 06; 76:47-51.
Score: 0.005
-
Patient-Reported Barriers to the Prekidney Transplant Evaluation in an At-Risk Population in the United States. Prog Transplant. 2017 06; 27(2):131-138.
Score: 0.005
-
Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics Approach. Int J Mol Sci. 2017 Mar 18; 18(3).
Score: 0.005
-
C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus. Immunology. 2015 Sep; 146(1):130-43.
Score: 0.004
-
Genetic and epigenetic variants contributing to clofarabine cytotoxicity. Hum Mol Genet. 2013 Oct 01; 22(19):4007-20.
Score: 0.004